Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryErica J. Brenner, Michael D. Kappelman, Ryan C. Ungaro et al.|Gastroenterology|2020Cited by 692
Increased Intestinal Permeability Is Associated With Later Development of Crohn’s DiseaseWilliams Turpin, Lee A. Denson, Wei Xu et al.|Gastroenterology|2020Cited by 308
Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal AnalysesMichael Buie, Maojuan Li, Joshua Quan et al.|Clinical Gastroenterology and Hepatology|2022Cited by 271
Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing CholangitisDavid Kevans, Mark S. Silverberg, Andrea D. Tyler et al.|Journal of Crohn s and Colitis|2015Cited by 91